SciSight Ecosystem
WoS SCIE Q2Scopus Q1SCImago #3,388CAS 3区Hybrid

Cytotherapy

Abbreviation (ISO):CYTOTHERAPY
Country: Norway•WoS SCIE Quartile: Q2•Scopus SJR: 1.249•SCImago Rank: #3,388•Identifier (ISSN):1465-3249(Print)/1477-2566(Online)•Articles / Year: 126•Estimated Publication Fee (APC): $3,392 USD
Clarivate IF (2026)Q2
4.5
↑ +1.3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
76

76 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate8.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
126articles/year
33.33% Gold OA•81.42% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

2.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 3.0(IF: 4.5)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20262.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.5)
🔵 Computed
20252.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.2)
🔵 Computed
20242.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.7)
🔵 Computed
20232.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.5)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.196)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.414)
🔵 Computed
20202.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.218)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.297)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.993)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The journal brings readers the latest developments in the fast moving field of cellular therapy in man. This includes cell therapy for cancer, immune disorders, inherited diseases, tissue repair and regenerative medicine. The journal covers the science, translational development and treatment with variety of cell types including hematopoietic stem cells, immune cells (dendritic cells, NK, cells, T cells, antigen presenting cells) mesenchymal stromal cells, adipose cells, nerve, muscle, vascular and endothelial cells, and induced pluripotential stem cells. We also welcome manuscripts on subcellular derivatives such as exosomes. A specific focus is on translational research that brings cell therapy to the clinic. Cytotherapy publishes original papers, reviews, position papers editorials, commentaries and letters to the editor. We welcome "Protocols in Cytotherapy" bringing standard operating procedure for production specific cell types for clinical use within the reach of the readership.

Topics Covered (Recognized by AI)
Biology86.1%Medicine81.5%Genetics78.9%Chemistry64.7%Internal medicine61.6%Cell biology60%Biochemistry58.6%Immunology51.5%Pathology48.9%Stem cell38.1%Cancer research31.6%Mesenchymal stem cell29.5%In vitro28.6%Gene23%Surgery22.7%Cell22.4%

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,388Scopus Q1SCImago Profile
Scopus Coverage:1999-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
1.249

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
115

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
4.15

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,392 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,748
3-Year Documents449
Citable Documents433

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Genetics (clinical)Q1
OncologyQ1
TransplantationQ1
Cancer ResearchQ2
Cell BiologyQ2
ImmunologyQ2
Immunology and AllergyQ2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CELL & TISSUE ENGINEERING
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Elsevier Inc.
Publication Language
English
Frequency
Bimonthly
Founding Year
1999
Editorial Address
TAYLOR & FRANCIS AS, KARL JOHANS GATE 5, OSLO, NORWAY, NO-0154
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
JCRSCIE
57/180Q2
CELL & TISSUE ENGINEERING
JCRSCIE
14/32Q2
CELL BIOLOGY
JCRSCIE
91/207Q2
HEMATOLOGY
JCRSCIE
22/103Q1
MEDICINE, RESEARCH & EXPERIMENTAL
JCRSCIE
59/191Q2
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
JCISCIE
63/180Q2
CELL & TISSUE ENGINEERING
JCISCIE
11/32Q2
CELL BIOLOGY
JCISCIE
78/207Q2
HEMATOLOGY
JCISCIE
25/103Q1
MEDICINE, RESEARCH & EXPERIMENTAL
JCISCIE
65/191Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—79249
20253.2755748
20243.77801,753
20234.57831,879
20226.1966632,049
20215.4146562,431
20204.2186613,787
20194.2974454,014
20183.9935645,146
2017—5945,444
2016—4776,802
2015—5136,826
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Cytotherapy

WoS Q2
2468201820192020202120222023202420253.20
Annual Impact Factor Metric
2025:3.2

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 8.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f386a7dc-313e-4d9a-b1fd-9a83ce1455b6
Database Updated: 2026-10-01